Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 8, 2004
Health-related quality of life in cardiac patients with dyslipidemia and hypertension
Lyne Lalonde, Annette O'Connor, Lawrence Joseph, et al.
The Canadian Journal of Cardiology
|
May 10, 2007
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Steven A Grover, Louis Coupal, Mohammed Kaouache, et al.
The Canadian Journal of Cardiology
|
February 28, 2021
Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
Steven A Grover, Hiba Jekki, Mohammed Kaouache, et al.
Archives of Internal Medicine
|
October 28, 2009
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels
Steven A Grover, Mohammed Kaouache, Lawrence Joseph, et al.
The American Journal of Medicine
|
August 2, 2003
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor
Steven A Grover, Louis Coupal, Hanna Zowall, et al.
Archives of Internal Medicine
|
February 13, 2003
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Steven A Grover, Vivian Ho, Frédéric Lavoie, et al.
The Canadian Journal of Cardiology
|
July 9, 2005
Cost-effectiveness of lipid-lowering treatment according to lipid level
Louise Pilote, Vivian Ho, Frédéric Lavoie, et al.
Journal of Occupational and Environmental Medicine
|
December 5, 2017
The Measurable Benefits of a Workplace Wellness Program in Canada: Results After One Year
Ilka Lowensteyn, Violette Berberian, Patrick Belisle, et al.
Pharmacotherapy
|
August 12, 2004
Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease
Lyne Lalonde, Annette M O'Connor, Elizabeth Drake, et al.
Open Forum Infectious Diseases
|
February 15, 2022
Outpatient Therapies for COVID-19: How Do We Choose?
Todd C Lee, Andrew M Morris, Steven A Grover, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 8, 2004
Health-related quality of life in cardiac patients with dyslipidemia and hypertension
Lyne Lalonde, Annette O'Connor, Lawrence Joseph, et al.
The Canadian Journal of Cardiology
|
May 10, 2007
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Steven A Grover, Louis Coupal, Mohammed Kaouache, et al.
The Canadian Journal of Cardiology
|
February 28, 2021
Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
Steven A Grover, Hiba Jekki, Mohammed Kaouache, et al.
Archives of Internal Medicine
|
October 28, 2009
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels
Steven A Grover, Mohammed Kaouache, Lawrence Joseph, et al.
The American Journal of Medicine
|
August 2, 2003
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor
Steven A Grover, Louis Coupal, Hanna Zowall, et al.
Archives of Internal Medicine
|
February 13, 2003
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Steven A Grover, Vivian Ho, Frédéric Lavoie, et al.
The Canadian Journal of Cardiology
|
July 9, 2005
Cost-effectiveness of lipid-lowering treatment according to lipid level
Louise Pilote, Vivian Ho, Frédéric Lavoie, et al.
Journal of Occupational and Environmental Medicine
|
December 5, 2017
The Measurable Benefits of a Workplace Wellness Program in Canada: Results After One Year
Ilka Lowensteyn, Violette Berberian, Patrick Belisle, et al.
Pharmacotherapy
|
August 12, 2004
Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease
Lyne Lalonde, Annette M O'Connor, Elizabeth Drake, et al.
Open Forum Infectious Diseases
|
February 15, 2022
Outpatient Therapies for COVID-19: How Do We Choose?
Todd C Lee, Andrew M Morris, Steven A Grover, et al.
Page
of 4